{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-22-000021","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2022-04-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.390742+00:00","generated_at":"2026-06-26T04:25:28.201224+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Integra LifeSciences Q1 adjusted EPS $0.74 beats prior year; raises FY organic growth guidance to 3.8%-5.2%","bullets":["Revenues $376.6M (+4.6% reported, +5.6% organic); adjusted EPS $0.74 vs $0.69 Q1 2021; GAAP EPS $0.39 (down from $0.53, prior year included $42.9M divestiture gain).","Codman Specialty Surgical rev $247.3M (org +5.0%); Tissue Technologies $129.3M (org +6.9%).","FY 2022 organic growth guidance raised to 3.8%-5.2% (from 3.5%-5.0%); reported revenue reaffirmed $1.58B-$1.60B; adjusted EPS reaffirmed $3.27-$3.35.","Board authorized new $225M share repurchase program (expires Dec 2024), replacing prior $225M program; completed $125M ASR in Q1."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-22-000021","json":"https://secwatch.observer/filing/0000917520-22-000021.json","markdown":"https://secwatch.observer/filing/0000917520-22-000021.md","text":"https://secwatch.observer/filing/0000917520-22-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752022000021/0000917520-22-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752022000021/iart-20220426.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T04:25:28.201224+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}